ABSTRACT Cecropin A, a 37-residue antibacterial peptide amide, was synthesized by the solid-phase method. It was shown to be homogeneous and totally indistinguishable from natural cecropin A by chemical and physical criteria, as well as by its antibacterial activity against several Gram-positive and Gram-negative organisms. The synthetic material was also used to establish unambiguously that the carboxyl-terminal blockdng group of natural cecropin A is a primary amide as tentatively proposed earlier.
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The role of the amino terminus of cecropin A in antibacterial activity was investigated by the synthesis of two analogs.
The immune system of the Cecropia moth and several other lepidopteran insects is characterized by an effective humoral response which is mainly associated with the cecropins, a recently discovered family of antibacterial peptides (1, 2). The three major cecropins-A, B, and D-have been purified from immune hemolymph and their sequences have been elucidated (3) (4) (5) . Other cecropin-like minor hemolymph components have also been partially characterized (5) . All cecropins are small (Mr 4,000) basic peptides with a high degree of mutual sequence homology. Synthesis of cecropin A-(1-33) was recently reported by Merrifield et al. (6) . This was initially assumed to be the complete molecule, on the basis of the sequence data then available. However, the difference in electrophoretic mobility between the synthetic and natural peptides prompted further investigation of the sequence, which resulted in the finding that cecropin A was in fact a 37-residue peptide with an unspecified blocking group at the carboxyl end, tentatively assumed to be an amide. Our next goal then has been to synthesize the complete cecropin A-(1-37) molecule having a primary carboxamide at the carboxyl terminus. We now report this synthesis, which allows the definitive confirmation of the structure proposed for cecropin A (3).
MATERUILS AND METHODS Reagents. t-Butyloxycarbonyl (Boc)-protected amino acids were purchased from Peninsula Laboratories (San Carlos, CA), except for Boc-Asp(OcHx)-OH and Boc-Glu(OcHx)-OH (cHx = cyclohexyl), which were prepared in our laboratory by described procedures (7). Boc-[3H]Ala-OH and Boc-['4C]Leu-OH were prepared from 0.25-mCi samples (1 Ci = 3.7 X 10'°Bq) of the free amino acid (New England Nuclear) by appropriate dilutions with nonradioactive amino acid and subsequent reaction with Boc2O (8) . Other reagents were trifluoroacetic acid (F3CCOOH) (Halocarbon Products, Hackensack, NJ), HF (Matheson), diisopropylethylamine (DIEA) (Aldrich) distilled over nihydrin (Pierce) and CaH2, dicyclohexylcarbodiimide (DCC) (Pierce), 1-hydroxybenzotriazole (HOBt) (Aldrich) recrystallized from ethanol, p-cresol (Aldrich), p-thiocresol (Fluka), and dimethyl sulfide (Me2S) (Fluka). Main solvents were dichloromethane (Fisher) distilled from anhydrous Na2CO3, dimethylformamide (DMF) (MCB Chemical, Norwood, OH) dried over 4-A molecular sieves, and HPLC-grade acetonitrile (Fisher).
Synthetic Protocol. Peptides were synthesized manually by a stepwise strategy. Attachment of the peptide chain to the copoly(styrene-1%-divinylbenzene) matrix was through a benzhydrylamine-type handle. The general procedure for each synthetic cycle, based on 5 g of initial resin, is as follows: (1) CH2Cl2, 70 ml, 4 x 1 min; (2) 50% (vol/vol) F3CCOOH/CH2Cl2, 70 ml, 2 X 1 min; (3) 50% F3CCOOH/CH2Cl2, 70 ml, 20 min; (4) CH2Cl2, 70 ml, 6 X 1 min; (5) 5% DIEA/CH2CI2, 70 ml, 2 X 2 min; (6) CH2Cl2, 70 ml, 6 x 1 min; (7) protected amino acid, 8 eq in 25 ml of CH2Cl2, 0WC, add DCC, 4 eq in 5 ml of CH2Cl2; after 10 min at 0°C, filter, add to reaction vessel, rinse with 20 ml of CH2Cl2, shake for 2 hr at room temperature; (8) CH2Cl2, 70 ml, 6 X 1 min; (9) 5% DIEA/CH2CI2, 70 ml, 2 min; (10) CH2Cl2, 70 ml, 4 X 1 min; (11) DMF, 70 ml, 2 X 2 min; (12) HOBt, 4 eq in 15 ml of DMF, add DCC, 4 eq in 5 ml of CH2Cl2, add protected amino acid in 10 ml of DMF; after 10 min at 0°C add to reaction vessel, rinse with 20 ml of DMF, and shake for 2 hr (occasionally overnight) at room temperature; (13) DMF, 70 ml, 2 X 2 min; (14) CH2Cl2, 70 ml, 4 X 1 min; (15) 5% DIEA/ CH2C12, 70 ml, 2 min; (16) CH2Cl2, 70 ml, 6 X 1 min; (17) 2-to 5-mg sample for ninhydrin. Some modifications introduced in this general procedure for particular amino acids are described in Results.
Assay for Antibacterial Activity. A modification of the classical assay for antibiotics was used. Inhibition zones were measured around wells (1.5-to 2.0-mm diameter) in thin agar plates containing rich medium and about 2 x 105 bacterial cells (5) . Lethal concentrations were calculated from the diameters of the zones obtained in serial dilutions of the test substance by using the formula given in ref. 9 .
RESULTS
Solid-Phase Synthesis of Cecropin A. The synthesis was designed to obtain cecropin A by a stepwise strategy. This approach involved the use of a benzhydrylamine-type resin as solid support combined with N-protection with the acid-labile Boc group and side chain protection with more acid-stable, benzyltype groups. The structure of the synthetic protected cecropin A-resin is as follows:
Abbreviations: Boc, t-butyloxycarbonyl; Bzl, benzyl, C1Z, 2-chlorobenzyloxycarbonyl; cHx, cyclohexyl; DCC, dicyclohexylcarbodiimide; DIEA, diisopropylethylamine; DMF, dimethylformamide; HOBt, 1-hydroxybenzotriazole; Me2S, dimethyl sulfide; Tos, p-toluenesulfonyl.
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in which CIZ is 2-chlorobenzyloxycarbonyl, Tos is p-toluenesulfonyl, Bzl is benzyl, and (®) is the resin.
The solid support chosen was a modification of a previously developed multidetachable benzhydrylamine resin (10) . The initial substitution on the support at the Lys-37 level was 0.125 mmol/g of resin. All subsequent amino acids were incorporated by following a double-coupling protocol with some modifications for particular amino acids. For all residues except arginine, asparagine and glutamine, and the two residues of glycine coupled to glutamine, the first coupling was with the preformed symmetric anhydride (11) in CH2CI2 and the second was with the preformed HOBt ester (12) in DMF. For Boc-Arg(ros)-OH, standard DCC coupling conditions that avoid the risk of lactam formation were preferred in the first coupling, the second being with the HOBt ester in DMF. Boc-Asn-OH and Boc-Gln-OH were exclusively coupled as HOBt esters in DMF to reduce nitrile and amidine formation (13) . For addition of Gly-12 and Gly-30 to Glu-13 and Glu-31, the first coupling was with the symmetric anhydride in DMF to minimize pyrrolidone carboxylic acid (<Glu) formation (14) . For radiolabeled Ala-36, the first coupling was with 2.0 eq each of Boc-[3H]Ala-OH and DCC and the second with the HOBt ester of the nonradioactive amino acid. For Leu-4, two standard DCC couplings with 2 eq of Boc-
[14C]Leu-OH were done. The specific activities of these residues after incorporation were 0.22 mCi/mmol and 0.55 mCi/ mmol, respectively.
The quantitative ninhydrin reaction (15) was routinely used throughout the synthesis to monitor the extent of coupling after each cycle. According to this method, additional couplings were shown to be necessary at residues Gln-13, Asn-14, Ile-19, Val-26, Val-28, and Thr-33; these couplings were done with the symmetric anhydride in DMF. The substitution of the polymer was also regularly checked during the synthesis by the same method. The final substitution value of the peptide was 0.040 mmol/g of styrene, reflecting a substantial decrease in the number of growing peptide chains in the course of the synthesis. Two factors seemed to account for this. On the one hand, a sharp 15% drop in substitution took place between residues Gln-31 and Gly-30 and was attributed to <Glu formation, despite the precautions described above. Further confirmation came by the isolation of a terminated heptapeptide, <Glu-AlaThr-Gln-Ile-Ala-Lys-NH2, which is described below. On the other hand, a minor nonspecific decrease in substitution was observed at every cycle, amounting to an average 1.4% per step. This was later shown to be due to cleavage by HOBt of the nucleophile-sensitive phenyl ester bond between the benzhydrylamine moiety and the polymer matrix. The stability of the solid support to HOBt was further investigated by treating peptide-resin samples with 4 eq of HOBt in DMF and monitoring the radioactivity of the solution at several time points. The data indicated that, in 'the absence of other nucleophiles, the release of peptide from the resin was initially rather fast but after 1.5 hr reached a plateau in which about 2.5% of the total peptide was present in the solution. The crude peptide was purified by cation-exchange chromatography on carboxymethyl-Sepharose (Fig. 1) , using a linear 0.1-1.0 M ammonium formate gradient at pH 6.6. The UVabsorbing peaks in the frontal region of the chromatogram correspond to p-cresol and other nonpeptide impurities derived from the HF reaction. However, radioactivity monitoring of the fractions in this region allowed the detection of a very small amount of a 3H-labeled peak that was transparent at 280 nm and eluted with some of the nonpeptide material. Its thesis. This peptide was partially purified by HPLC (not shown) and analyzed. The amino acid composition was Lys1Glu2-Thr1Ala2Ilel, consistent with the heptapeptide <Glu-Ala-ThrGln-Ile-Ala-Lys-NH2 resulting from termination at the Gln-31 residue and confirming the substitution drop at this level referred to above. The main peak in the chromatogram eluted at an ammonium formate concentration of about 0.4 M. The fractions corresponding to the hatched region in Fig. 1 were collected and further purified by semipreparative reverse-phase HPLC (Fig. 2) . The major peak corresponded to cecropin A and accounted for 70% of the eluted material. The overall purification yield (two steps) was 25%. The purified synthetic cecropin A had the correct amino acid composition (Table 1) and was homogeneous by analytical reverse-phase HPLC and sodium dodecyl sulfate/polyacrylamide gel electrophoresis in urea at pH 7.2 (data not shown). It was also found to be completely indistinguishable from natural cecropin A by polyacrylamide gel electrophoresis at pH 4.0 (Fig. 3) .
Analogs. Two cecropin A analogs, -cecropin A-(3-37) and geneity by HPLC. Amino acid analyses for both peptides are given in Table 1 .
Confirmation of the Carboxyl-Terminal Structure of Cecropin A. Final confirmation of the structure of cecropin A was done by submitting both natural and synthetic peptides to digestion with inhibitor A protease in 0.1 M phosphate buffer, pH 6.4, at 37TC, with an inhibitor A-to-cecropin ratio of 1:100 (wt/wt), corresponding to a molar ratio of 1:2,-000. Inhibitor A is. a protein isolated from Bacillus thuringiensis that was detected as an immune inhibitor (18) and recently shown (unpublished data) to be a protease with a pronounced specificity for the cecropins and attacins in immune hemolymph. Both digests were then analyzed by HPLC and shown to be identical (Fig. 4) except for the slight shoulder at 19.43 min in the synthetic sample digest, which has also been previously observed in incompletely digested natural cecropin A samples. The 3H- (Table 2) showed synthetic cecropin A to be equally active against all four organisms and thus further confirmed the identity between the natural and synthetic materials. In addition to the chromatographic and electrophoretic criteria mentioned above, definitive confirmation of the identity between natural and synthetic cecropin A came from their inhibitor protease fragment patterns in HPLC (Fig. 4) and from their antibacterial activities against the four different bacteria selected as test organisms (Table 2 ). In the first case, the presence of a radioactive label in the synthetic peptide allowed us to locate with certainty its carboxyl-terminal pentapeptide in the HPLC of its digest and thus to identify the corresponding proteolytic pentapeptide from natural cecropin A. Mass spectroscopy of this fragment showed the presence of a primary amide group on the carboxyl-terminal lysine residue, a feature now definitively established. In this respect, cecropin A is like melittin and some of the peptide hormones. Cecropin A-(1-33) has one-less -NH2 and one more -COOH than the complete molecule, and accordingly it shows a lower mobility at pH 4 ( Fig. 3) . Cecropin A-(3-37) should have one less positive charge than the complete molecule and was also expected to move somewhat slower. The reason for its anomalous behavior is not clear at this time.
The available data on the mode of action of the cecropins indicate that they disrupt the membranes of Gram-negative bacteria (3) . A weak activity of cecropin A-(1-33) against B. megaterium was demonstrated earlier by an antibacterial assay on polyacrylamide gels, but the effect was too low to be estimated quantitatively (6) . Table 2 now shows that by inhibition zone assay both synthetic and natural cecropin A have a good activity against the Gram-positive organisms B. megaterium and M. luteus. Assuming that cecropins do not act on the murein sacculus, we can conclude that cecropin A acts against the cytoplasmic membrane. Because both of these organisms are extremely sensitive to lysozyme and because the presence of minute contaminations of Cecropia lysozyme in natural isolated cecropin A could not totally be ruled out, an unambiguous conclusion about the activity of natural cecropin A was not possible. The synthetic material, which does not contain lysozyme, was a prerequisite for this conclusion.
The lethal concentrations given in Table 2 show that the carboxy terminus of cecropin A is of minor importance for the activity against E. coli, which is in agreement with our previous slightly less accurate results (6) . However, for the three other bacteria tested, the removal of the carboxyl-terminal tetrapeptide amide reduced activity to 3 to 20%. In the case of the removal of the amino-terminal dipeptide all activities were reduced, varying from 1/8th for E. coli to a total loss of activity for M. luteus. The ends of cecropin A seem, therefore, to be needed to different degrees against different bacteria. These results show that there is a considerable degree of specificity in the structure of cecropin A and suggest that the entire molecule is the result of selection pressure created by a need for insects to protect themselves from a number of different microorganisms.
